About Mach5 Therapeutics
Mach5 Therapeutics is a private company based in Atlanta, Georgia, incorporated in 2023 in Delaware. It has reported $23,354,509 raised in two offerings on Form D since April 2024. Its chief executive is Patrick Crutcher.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Oct 24, 2024 | Nov 4, 2024 | $19,179,509of $19.9M target | 15 | $1.2M | EquityRule 506(b) | Form D ↗ |
| Mar 21, 2024 | Apr 3, 2024amended Apr 17, 2024 | $4,175,000of $4.5M target | 7 | $596K | EquityRule 506(b) | Form D/A ↗1 earlier filing |
| Total, two offerings | $23,354,509 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Mach5 Therapeutics's Form D filed Nov 4, 2024.
PC
Patrick Crutcher
Chief Executive Officer and director
JD
Justin DiMartino
Executive officer and director